- Home
- LCTX vs BSET Comparison
LCTX vs BSET Comparison
Compare LCTX & BSET Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- LCTX
- BSET
- Stock Information
- Founded
- LCTX 1990
- BSET 1902
- Country
- LCTX United States
- BSET United States
- Employees
- LCTX N/A
- BSET N/A
- Industry
- LCTX Biotechnology: Biological Products (No Diagnostic Substances)
- BSET Home Furnishings
- Sector
- LCTX Health Care
- BSET Consumer Discretionary
- Exchange
- LCTX Nasdaq
- BSET Nasdaq
- Market Cap
- LCTX 127.7M
- BSET 134.7M
- IPO Year
- LCTX N/A
- BSET 1987
- Fundamental
- Price
- LCTX $0.62
- BSET $14.38
- Analyst Decision
- LCTX Strong Buy
- BSET
- Analyst Count
- LCTX 5
- BSET 0
- Target Price
- LCTX $4.80
- BSET N/A
- AVG Volume (30 Days)
- LCTX 2.4M
- BSET 10.6K
- Earning Date
- LCTX 03-06-2025
- BSET 01-31-2025
- Dividend Yield
- LCTX N/A
- BSET 5.69%
- EPS Growth
- LCTX N/A
- BSET N/A
- EPS
- LCTX N/A
- BSET N/A
- Revenue
- LCTX $8,719,000.00
- BSET $340,285,000.00
- Revenue This Year
- LCTX N/A
- BSET N/A
- Revenue Next Year
- LCTX $41.15
- BSET $1.77
- P/E Ratio
- LCTX N/A
- BSET N/A
- Revenue Growth
- LCTX N/A
- BSET N/A
- 52 Week Low
- LCTX $0.48
- BSET $12.11
- 52 Week High
- LCTX $1.61
- BSET $16.50
- Technical
- Relative Strength Index (RSI)
- LCTX 56.03
- BSET 56.27
- Support Level
- LCTX $0.55
- BSET $13.66
- Resistance Level
- LCTX $0.60
- BSET $14.47
- Average True Range (ATR)
- LCTX 0.04
- BSET 0.30
- MACD
- LCTX 0.01
- BSET 0.06
- Stochastic Oscillator
- LCTX 100.00
- BSET 89.27
About LCTX Lineage Cell Therapeutics Inc.
Lineage Cell Therapeutics Inc is a clinical-stage biotechnology company focused on the development and commercialization of novel therapies for the treatment of degenerative diseases. The company's pipeline is based on two platform technologies including cell replacement and cell/drug delivery. Lineage Cell's product candidate is OpRegen, a retinal pigment epithelium transplant therapy for the treatment of dry age-related macular degeneration, OPC1, an oligodendrocyte progenitor cell therapy for acute spinal cord injuries, and VAC2, allogeneic cancer immunotherapy of antigen-presenting dendritic cells for non-small cell lung cancer, ANP1, an allogeneic auditory neuron progenitor cells transplant for hearing loss, and PNC1, an allogeneic photoreceptor cell transplant for vision loss.
About BSET Bassett Furniture Industries Incorporated
Bassett Furniture Industries Inc is a manufacturer, marketer, and retailer of home furnishings products in the United States. It operates through the following segments: The Wholesale segment focuses on the design, manufacture, sourcing, sale, and distribution of furniture products, the Retail segment which consists of company-owned stores, and the Corporate and others segment.